How Cells Ship Proteins Into Mitochondria Using Molecular Gatekeeping Machines
A landmark review reveals the structural machinery governing how ~1,500 proteins are imported into mitochondria, with direct implications for aging and disease.
Summary
Mitochondria depend on elaborate protein import systems to receive nearly all of their ~1,000–1,500 proteins, which are made outside the organelle in the cell's cytosol. A comprehensive 2025 review in Nature Reviews Molecular Cell Biology by Endo and Wiedemann maps the molecular machines — including the TOM, SAM, and TIM complexes — that shuttle these proteins across mitochondrial membranes. The review integrates recent high-resolution structural data to explain how targeting signals guide proteins to the right compartment, how energy powers the process, and how cells correct misdirected proteins. Understanding these pathways is increasingly important for aging biology, as mitochondrial import efficiency declines with age and is disrupted in neurodegeneration, metabolic disease, and cancer.
Detailed Summary
Mitochondria are central to cellular energy production, metabolism, and stress signaling — and their dysfunction is a hallmark of aging. Yet the vast majority of mitochondrial proteins are not made inside the organelle; they are encoded in the nuclear genome, synthesized in the cytosol, and must be physically transported into the correct mitochondrial compartment. How this massive logistical operation is orchestrated with precision is the subject of this comprehensive review.
Endo and Wiedemann survey the complete landscape of mitochondrial protein import machinery. The outer mitochondrial membrane hosts the TOM complex (Translocase of the Outer Membrane), the primary entry gate for nearly all incoming proteins, and the SAM complex (Sorting and Assembly Machinery), which integrates beta-barrel proteins into the outer membrane. The inner membrane contains multiple TIM complexes (TIM23 and TIM22) that handle matrix-targeted and membrane-integrated proteins respectively.
A major focus of the review is the integration of recent cryo-electron microscopy and structural biology breakthroughs that have revealed, at near-atomic resolution, how these translocases recognize targeting signals and physically thread proteins across hydrophobic lipid bilayers. The energetics of import — driven by membrane potential and ATP hydrolysis — are also detailed.
The review also addresses emerging concepts: how proteins can shift localization between compartments under stress, and quality-control mechanisms that catch and reroute mislocalized proteins before they cause damage. These 'corrective' pathways are increasingly recognized as relevant to disease states.
For longevity researchers, the significance is clear: mitochondrial import fidelity declines with age, and defects in TOM/TIM machinery are linked to Parkinson's disease, neurodegeneration, and metabolic disorders. This review provides a foundational framework for understanding and potentially targeting these processes therapeutically.
Key Findings
- TOM, SAM, and TIM complexes form the core machinery importing ~1,000–1,500 proteins into mitochondria from the cytosol.
- Recent structural data reveal near-atomic resolution mechanisms of how translocases recognize targeting signals and move proteins.
- Membrane electrochemical potential and ATP hydrolysis provide the energy driving protein import across mitochondrial membranes.
- Cells possess active quality-control pathways to detect and correct mislocalized mitochondrial proteins.
- Disruption of import machinery is implicated in aging, neurodegeneration, and metabolic disease.
Methodology
This is a comprehensive expert review article published in Nature Reviews Molecular Cell Biology, synthesizing decades of biochemical, genetic, and structural research. The authors draw heavily on recent cryo-EM structural studies to update mechanistic models of protein transport. No primary experimental data are presented; conclusions are based on synthesis of published literature.
Study Limitations
As a review article, this work does not present new experimental findings and is subject to the completeness and interpretation biases of its authors. The field's structural understanding remains incomplete for several translocase components. Translating mechanistic insights from yeast and cell models — which dominate this literature — to human aging contexts requires further validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: